With a market capitalisation of just ₹111.00 crores, Nexome Capital Markets operates in the competitive NBFC space, primarily engaged in merchant banking and trading in government securities and shares. The company's Q4 FY26 results represent a dramatic reversal from previous quarters, yet the broader financial trajectory reveals persistent structural challenges that warrant careful investor scrutiny.
The company's stock has demonstrated significant volatility over longer timeframes, delivering 188.83% returns over three years and outperforming the Sensex by 165.21 percentage points. However, the current valuation at 68 times trailing earnings and a "Very Expensive" rating from quality assessments suggest limited margin of safety for fresh investors.
| Quarter | Mar'26 | Dec'25 | Sep'25 | Jun'25 | Mar'25 | Dec'24 | Sep'24 |
|---|---|---|---|---|---|---|---|
| Net Sales (₹ Cr) | 21.91 | 1.12 | 8.32 | 16.70 | 9.86 | 7.38 | 6.34 |
| QoQ Growth (%) | +1,856.25% | -86.54% | -50.18% | +69.37% | +33.60% | +16.40% | — |
| Net Profit (₹ Cr) | 9.45 | -1.00 | 1.00 | 1.27 | 0.31 | 0.25 | 0.25 |
| YoY Growth (%) | +2,948.39% | -500.00% | +300.00% | — | — | — | — |
| Operating Margin (%) | 67.46% | -97.32% | 12.26% | 8.56% | -5.88% | -4.61% | -5.52% |
| PAT Margin (%) | 43.13% | -89.29% | 12.02% | 7.60% | 3.14% | 3.39% | 3.94% |
Financial Performance: A Quarter of Extremes
Nexome Capital Markets' Q4 FY26 performance represents one of the most dramatic quarterly turnarounds in the NBFC sector, with net sales surging 1,856.25% quarter-on-quarter to ₹21.91 crores from a mere ₹1.12 crores in Q3 FY26. This exceptional growth was accompanied by an equally impressive expansion in operating margins, which jumped to 67.46% from negative territory in the previous quarter, marking the company's highest-ever quarterly margin.
The revenue surge translated into robust bottom-line growth, with net profit reaching ₹9.45 crores in Q4 FY26 compared to a loss of ₹1.00 crore in Q3 FY26. On a year-on-year basis, the company's profit grew 2,948.39% from ₹0.31 crores in Q4 FY25. The PAT margin expanded dramatically to 43.13%, reflecting exceptional operational efficiency during the quarter.
However, context is crucial when evaluating these numbers. The company's quarterly performance has been extraordinarily volatile, with revenue swinging wildly between ₹1.12 crores and ₹21.91 crores over recent quarters. This inconsistency raises questions about the sustainability and predictability of earnings, a critical concern for investors seeking stable returns in the NBFC space.
Employee costs remained relatively stable at ₹1.31 crores in Q4 FY26, up marginally from ₹1.26 crores in the previous quarter. Operating profit before depreciation, interest, and tax (excluding other income) stood at ₹14.78 crores, the highest in the company's recent history. Other income contributed ₹0.79 crores during the quarter, maintaining consistency with previous periods.
The tax expense for Q4 FY26 was ₹3.34 crores, representing an effective tax rate of 26.13%, significantly lower than the 46.55% rate in Q4 FY25. This normalisation of the tax rate contributed positively to the bottom line, though it also highlights the irregularity of previous periods' tax provisions.
Operational Challenges: Weak Capital Efficiency Persists
Despite the stellar quarterly performance, Nexome Capital Markets continues to struggle with fundamental operational weaknesses that undermine long-term investment appeal. The company's average return on equity stands at just 1.19%, significantly below industry standards and indicating poor capital deployment efficiency. Even the latest ROE of 1.82% remains anaemic, suggesting the company generates minimal returns for shareholders relative to the equity capital employed.
The company's return on capital employed (ROCE) paints an equally concerning picture at 0.43%, reflecting inefficient utilisation of total capital. For an NBFC operating in a competitive environment, such low returns on capital indicate either inadequate asset generation capabilities or excessive capital sitting idle without productive deployment.
Critical Concern: Capital Efficiency Crisis
Return on Equity (Average): 1.19% – Among the weakest in the NBFC sector
Return on Capital Employed: 0.43% – Indicates severe underutilisation of capital resources
Implication: The company struggles to generate meaningful returns from shareholder capital, raising questions about management's ability to identify and execute profitable opportunities. This structural weakness persists despite occasional strong quarters.
The balance sheet reveals shareholder funds of ₹153.84 crores as of March 2025, comprising share capital of ₹5.88 crores and reserves of ₹144.89 crores. The company maintains a debt-free status with zero long-term debt, which whilst reducing financial risk, also suggests limited leverage of growth opportunities typical in the NBFC business model.
Investments stood at ₹116.41 crores as of March 2025, representing the bulk of the company's asset base. Fixed assets totalled ₹5.02 crores, indicating a relatively light physical infrastructure. Current assets of just ₹2.53 crores against current liabilities of ₹14.58 crores point to potential working capital pressures, though the nature of the NBFC business may explain this structure.
Historical Context: A Pattern of Volatility
Examining Nexome Capital Markets' historical performance reveals a troubling pattern of inconsistency that extends well beyond recent quarters. For the full year FY25, the company reported net sales of ₹39.00 crores, representing an 83.3% decline from ₹234.00 crores in FY24. This dramatic contraction followed an equally dramatic 341.5% expansion in FY24, illustrating the extreme volatility characterising the company's operations.
The company's five-year sales growth rate stands at negative 9.36%, reflecting a sustained inability to build a stable, growing revenue base. Whilst EBIT growth over the same period shows a positive 8.96%, the absolute levels remain modest and inconsistent. The company has oscillated between profits and losses across multiple years, with full-year PAT of ₹1.00 crore in FY25 and ₹2.00 crores in FY24.
| Year | Mar'25 | Mar'24 | Mar'23 | Mar'22 | Mar'21 |
|---|---|---|---|---|---|
| Net Sales (₹ Cr) | 39.00 | 234.00 | 53.00 | 67.00 | 68.00 |
| YoY Growth (%) | -83.3% | +341.5% | -20.9% | -1.5% | +54.5% |
| Operating Margin (Excl OI) % | -2.6% | -0.9% | -5.7% | -3.0% | -1.5% |
| PAT (₹ Cr) | 1.00 | 2.00 | 0.00 | 2.00 | 0.00 |
| PAT Margin (%) | 2.6% | 0.9% | 0.0% | 3.0% | 0.0% |
Notably, the company has consistently reported negative operating margins (excluding other income) across all recent years, ranging from negative 0.9% to negative 6.8%. This indicates that the core business operations have failed to generate positive cash flows before considering other income, a red flag for any operating company but particularly concerning for an NBFC.
Cash flow analysis reveals further concerns. Operating cash flows have been negative in most recent years, with FY25 showing negative ₹6.00 crores and FY24 showing negative ₹4.00 crores. The company has relied on financing activities (₹7.00 crores inflow in FY25) to bridge operational shortfalls, raising questions about the sustainability of the business model without external capital infusions.
Peer Comparison: Trailing Industry Standards
When benchmarked against peers in the NBFC sector, Nexome Capital Markets' fundamental weaknesses become even more apparent. The company's ROE of 1.19% significantly lags the peer group average, with competitors like Titan Securities delivering 15.85% and Thacker & Company achieving 11.15%. This disparity underscores the company's inability to compete effectively on capital efficiency metrics.
| Company | P/E (TTM) | P/BV | ROE (%) | Debt to Equity | Div Yield (%) |
|---|---|---|---|---|---|
| Nexome Cap. Mkt. | 67.95 | 0.69 | 1.19% | 0.04 | NA |
| Garnet Intl. | 25.88 | 2.84 | 4.73% | 0.02 | NA |
| Titan Securities | 10.09 | 1.02 | 15.85% | 0.00 | NA |
| Thacker & Co. | 6.32 | 0.72 | 11.15% | 0.00 | NA |
| Indian Infotech | NA (Loss Making) | 0.40 | 0.21% | 0.00 | NA |
| Arunjyoti Bio | NA (Loss Making) | 3.62 | 4.74% | 0.78 | NA |
Valuation metrics present a mixed picture. Nexome Capital Markets trades at a P/E ratio of 67.95 times, substantially higher than peers like Titan Securities (10.09x) and Thacker & Company (6.32x), and well above the industry average of 20x. This premium valuation appears unjustified given the company's weak fundamental metrics and inconsistent earnings history.
However, the price-to-book ratio of 0.69x suggests the stock trades at a discount to book value, potentially offering some downside protection. This compares favourably to peers like Garnet International (2.84x) and Arunjyoti Bio (3.62x). The low P/BV multiple reflects market scepticism about the company's ability to generate returns above its cost of capital, consistent with the weak ROE metrics.
None of the peer companies offer dividend yields, indicating that capital returns to shareholders remain minimal across this segment of the NBFC universe. Nexome Capital Markets last paid a dividend of ₹1 per share in September 2018, nearly eight years ago, further highlighting the lack of shareholder returns.
Valuation Analysis: Premium Without Justification
At the current market price of ₹102.87, Nexome Capital Markets commands a market capitalisation of ₹111.00 crores, placing it firmly in the micro-cap category. The company's valuation metrics present a contradictory picture that warrants careful analysis before any investment decision.
The P/E ratio of 68 times trailing earnings represents a significant premium to both the industry average (20x) and most direct peers. This elevated multiple typically reflects expectations of strong future growth or superior business quality – neither of which appears justified in Nexome's case given the historical volatility and weak returns on capital. The market appears to be pricing in optimism based on the recent stellar quarter rather than the company's long-term track record.
Valuation Disconnect: Premium Multiple, Discount to Book
Nexome Capital Markets exhibits an unusual valuation profile: trading at 68x earnings (suggesting growth expectations) whilst simultaneously trading at 0.69x book value (suggesting value trap concerns). This disconnect reflects market uncertainty about whether Q4 FY26's exceptional performance marks a genuine turnaround or merely another spike in an otherwise volatile earnings pattern.
EV/EBITDA of 112.99x further confirms the stretched valuation, particularly concerning given the company's history of negative operating cash flows and minimal institutional interest (0% institutional holdings).
The EV/EBITDA multiple of 112.99x appears extraordinarily high, though this metric can be distorted for financial services companies with volatile earnings. The EV/Sales ratio of 3.14x provides another perspective, indicating investors are paying approximately three times annual revenue for the entire enterprise – a premium level typically reserved for high-growth, high-margin businesses.
The company's quality assessment has been downgraded over time, currently rated "Below Average" with a notation that valuation parameters have become very high compared to its past. The stock has oscillated between "Very Expensive" and "Expensive" ratings throughout 2025, most recently classified as "Very Expensive" since July 24, 2025.
Book value per share stands at ₹241.99, significantly above the current market price of ₹102.87, resulting in the P/BV ratio of 0.69x. This discount to book value might appear attractive on the surface, but it primarily reflects the market's recognition that the company's assets are not generating adequate returns. A low P/BV ratio is only compelling when accompanied by reasonable ROE; in Nexome's case, the 1.82% ROE suggests the book value itself may be overstated relative to earning power.
Stock Performance: Volatility Defines the Journey
Nexome Capital Markets' stock price behaviour mirrors the underlying business volatility, with dramatic swings across various timeframes that reflect both the company's inconsistent results and its micro-cap nature, which amplifies price movements.
| Period | Stock Return | Sensex Return | Alpha |
|---|---|---|---|
| 1 Week | +6.71% | +1.56% | +5.15% |
| 1 Month | -7.32% | -0.23% | -7.09% |
| 3 Months | +26.86% | -7.03% | +33.89% |
| 6 Months | +8.58% | -9.57% | +18.15% |
| Year-to-Date | -0.75% | -10.25% | +9.50% |
| 1 Year | +23.25% | -6.40% | +29.65% |
| 3 Years | +188.83% | +23.62% | +165.21% |
| 5 Years | +219.74% | +51.05% | +168.69% |
Over the past week, the stock has gained 6.71%, outperforming the Sensex by 5.15 percentage points. However, the one-month performance shows a decline of 7.32%, underperforming the broader market by 7.09 percentage points. This short-term volatility exemplifies the challenges investors face in timing entries and exits in such an unpredictable stock.
The three-month return of 26.86% demonstrates the stock's capacity for sharp rallies, generating 33.89 percentage points of alpha versus the Sensex. Yet this outperformance must be contextualised against the stock's high volatility of 60.89% (versus 13.00% for the Sensex), which places it firmly in the "High Risk High Return" category with a beta of 1.50.
Longer-term returns appear impressive on the surface: 188.83% over three years and 219.74% over five years. However, these gains have been accompanied by extreme volatility and significant drawdowns. The stock currently trades 34.70% below its 52-week high of ₹157.54, illustrating the magnitude of corrections investors must endure.
Technical analysis reveals a "Sideways" trend as of May 18, 2026, with the stock trading above all major moving averages (5-day, 20-day, 50-day, 100-day, and 200-day). Weekly MACD and KST indicators show bullish signals, though monthly indicators present a more mixed picture with mildly bearish MACD and KST readings.
Investment Thesis: Quality Concerns Override Single-Quarter Strength
The investment case for Nexome Capital Markets rests on a fundamental tension between the company's exceptional Q4 FY26 performance and its persistently weak underlying fundamentals. Whilst the recent quarter demonstrates the company's potential for strong results under favourable conditions, the historical pattern suggests these conditions are neither predictable nor sustainable.
The company's proprietary Mojo score of 37 out of 100 reflects this reality, placing it firmly in the "SELL" category. This score incorporates multiple dimensions of assessment: valuation (Very Expensive), quality (Below Average), financial trend (Outstanding for the recent quarter), and technical trend (Sideways). The overall assessment remains cautious despite the recent positive financial trend.
Key limiting factors include the weak long-term fundamental strength with an average ROE of just 1.19%, significantly below acceptable thresholds for profitable investment. The company's inability to generate consistent positive operating cash flows further undermines confidence in the business model's sustainability.
✓ KEY STRENGTHS
- Exceptional Q4 Performance: Net profit of ₹9.45 crores with 67.46% operating margin demonstrates potential
- Debt-Free Balance Sheet: Zero long-term debt reduces financial risk and provides flexibility
- Discount to Book Value: Trading at 0.69x P/BV offers some downside protection
- Strong Recent Price Momentum: 188.83% returns over three years significantly outpacing indices
- Outstanding Financial Trend: Recent quarter marks highest sales, profits, and margins in company history
⚠ KEY CONCERNS
- Abysmal Capital Efficiency: ROE of 1.82% and ROCE of 0.43% indicate severe underutilisation of resources
- Extreme Earnings Volatility: Revenue swings from ₹1.12 crores to ₹21.91 crores quarter-to-quarter
- Negative Operating Cash Flows: Persistent inability to generate positive cash from operations
- Stretched Valuation: P/E of 68x and EV/EBITDA of 112.99x appear unjustified given fundamentals
- Declining Long-Term Sales: Five-year sales growth of negative 9.36% shows deteriorating business
- Zero Institutional Interest: No institutional holdings signal lack of professional investor confidence
- High Volatility: 60.89% volatility and beta of 1.50 create significant downside risk
Outlook: What to Monitor Going Forward
For investors considering or holding Nexome Capital Markets, several key indicators will determine whether Q4 FY26's exceptional performance represents a genuine inflection point or merely another spike in a volatile pattern.
POSITIVE CATALYSTS
- Sustained Revenue Consistency: Maintaining quarterly sales above ₹15 crores for three consecutive quarters
- Margin Stabilisation: Operating margins consistently above 20% excluding other income
- Positive Operating Cash Flows: Generating positive cash from operations for two consecutive years
- ROE Improvement: Achieving ROE above 10% on a sustainable basis
RED FLAGS TO WATCH
- Revenue Collapse: Quarterly sales falling below ₹5 crores in any upcoming quarter
- Return to Losses: Reporting quarterly losses after the strong Q4 FY26 performance
- Continued Cash Burn: Negative operating cash flows persisting beyond FY26
- Further Valuation Expansion: P/E multiple rising above 75x without corresponding fundamental improvement
- Management Changes: Unexpected departures of key personnel or board members
The company's future trajectory will largely depend on its ability to convert the Q4 FY26 momentum into sustained operational improvements. Given the historical pattern of volatility, investors should demand evidence of consistency across at least three to four quarters before concluding that a genuine transformation has occurred.
The lack of institutional participation (0% institutional holdings) suggests that professional investors remain unconvinced about the company's prospects. Any material increase in institutional ownership would represent a positive signal, indicating that sophisticated investors have identified sustainable improvements in the business model.
The Verdict: Structural Weaknesses Trump Single-Quarter Excellence
Score: 37/100
For Fresh Investors: Avoid initiating positions despite the impressive Q4 FY26 results. The combination of extremely weak capital efficiency (1.82% ROE), stretched valuations (68x P/E), and a long history of volatile, unpredictable earnings creates an unfavourable risk-reward profile. The stock's 60.89% volatility and high beta of 1.50 amplify downside risks that are not adequately compensated by the potential upside.
For Existing Holders: Consider using any strength to exit positions or at minimum reduce exposure significantly. Whilst Q4 FY26 was exceptional, the company has failed to demonstrate the consistency required for sustainable wealth creation. The absence of institutional interest and negative operating cash flows raise serious questions about business model viability. Book partial profits and reallocate capital to higher-quality opportunities with more predictable earnings streams.
Fair Value Estimate: ₹75-80 (27% downside from current levels), based on a normalised P/BV of 0.50x applied to book value of ₹241.99, adjusted for the company's sub-par ROE and inconsistent earnings history.
Note- ROCE= (EBIT - Other income)/(Capital Employed - Cash - Current Investments)
⚠️ Investment Disclaimer
This article is for educational and informational purposes only and should not be construed as financial advice. Investors should conduct their own due diligence, consider their risk tolerance and investment objectives, and consult with a qualified financial advisor before making any investment decisions. Past performance is not indicative of future results, and all investments carry risk of loss.
